Zoetis Inc  

(Public, NYSE:ZTS)   Watch this stock  
Find more results for ZTS
50.76
+0.29 (0.57%)
After Hours: 50.77 +0.01 (0.02%)
Aug 26, 5:05PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 50.47 - 51.16
52 week 38.26 - 52.64
Open 50.66
Vol / Avg. 2.71M/3.25M
Mkt cap 25.05B
P/E 39.66
Div/yield 0.09/0.75
EPS 1.28
Shares 495.39M
Beta 1.02
Inst. own 95%
Nov 1, 2016
Q3 2016 Zoetis Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 14, 2016
Zoetis Inc at Morgan Stanley Global Healthcare Conference - 10:30AM EDT - Add to calendar
Aug 3, 2016
Q2 2016 Zoetis Inc Earnings Release
Aug 3, 2016
Q2 2016 Zoetis Inc Earnings Call - Webcast
Jun 14, 2016
Zoetis Inc at William Blair Growth Stock Conference
Jun 7, 2016
Zoetis Inc at Goldman Sachs Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '16) 2015
Net profit margin 18.54% 7.11%
Operating margin 27.48% 11.44%
EBITD margin - 27.24%
Return on average assets 12.00% 4.68%
Return on average equity 71.25% 28.50%
Employees 9,000 -
CDP Score - -

Address

100 Campus Dr
FLORHAM PARK, NJ 07932-1020
United States - Map
+1-973-8227000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.

Officers and directors

Juan Ramon Alaix Chief Executive Officer, Director
Age: 64
Bio & Compensation  - Reuters
Paul S. Herendeen Chief Financial Officer, Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Roxanne Lagano Chief Human Resource Officer, Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Heidi C. Chen Executive Vice President, General Counsel, Corporate Secretary
Age: 49
Bio & Compensation  - Reuters
Alejandro Bernal Executive Vice President, Group President - Strategy, Commercial and Business Development
Age: 43
Bio & Compensation  - Reuters
Catherine A. Knupp Executive Vice President, President - Research and Development
Age: 55
Bio & Compensation  - Reuters
Clinton A. Lewis Jr. Executive Vice President, President - International Operations
Age: 49
Bio & Compensation  - Reuters
Kristin C. Peck Executive Vice President, President - U.S. Operations
Age: 44
Bio & Compensation  - Reuters
Roman Trawicki Executive Vice President, President of Global Manufacturing and Supply
Age: 52
Bio & Compensation  - Reuters
Michael B. McCallister Non-Executive Independent Chairman of the Board
Age: 63
Bio & Compensation  - Reuters